These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

648 related articles for article (PubMed ID: 26561079)

  • 1. Dietary Supplement Therapies for Inflammatory Bowel Disease: Crohn's Disease and Ulcerative Colitis.
    Parian A; Limketkai BN
    Curr Pharm Des; 2016; 22(2):180-8. PubMed ID: 26561079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Dietary Supplements in Inflammatory Bowel Disease and Related Autoimmune Diseases.
    Jadhav P; Jiang Y; Jarr K; Layton C; Ashouri JF; Sinha SR
    Nutrients; 2020 Jul; 12(7):. PubMed ID: 32698454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nutraceutical Supplements for Inflammatory Bowel Disease.
    Parian AM; Limketkai BN; Shah ND; Mullin GE
    Nutr Clin Pract; 2015 Aug; 30(4):551-8. PubMed ID: 26024677
    [No Abstract]   [Full Text] [Related]  

  • 4. Nutritional Interventions in the Patient with Inflammatory Bowel Disease.
    Limketkai BN; Wolf A; Parian AM
    Gastroenterol Clin North Am; 2018 Mar; 47(1):155-177. PubMed ID: 29413010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Imbalance between n-6/n-3 Polyunsaturated Fatty Acids and Inflammatory Bowel Disease: A Comprehensive Review and Future Therapeutic Perspectives.
    Scaioli E; Liverani E; Belluzzi A
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29206211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of Saccharomyces boulardii as a treatment option in IBD.
    Sivananthan K; Petersen AM
    Immunopharmacol Immunotoxicol; 2018 Dec; 40(6):465-475. PubMed ID: 29771163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Rundown of Dietary Supplements and Their Effects on Inflammatory Bowel Disease-A Review.
    Malinowski B; Wiciński M; Sokołowska MM; Hill NA; Szambelan M
    Nutrients; 2020 May; 12(5):. PubMed ID: 32423084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunisation in children and adolescents with inflammatory bowel disease.
    Banaszkiewicz A; Radzikowski A; Albrecht P
    Adv Med Sci; 2015 Mar; 60(1):144-7. PubMed ID: 25689276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary Management of Pediatric Inflammatory Bowel Disease.
    Kaenkumchorn T; Kesavan A
    J Med Food; 2019 Nov; 22(11):1092-1099. PubMed ID: 31329006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of probiotics, prebiotics and synbiotics on the reduction of IBD complications, a periodic review during 2009-2020.
    Darb Emamie A; Rajabpour M; Ghanavati R; Asadolahi P; Farzi S; Sobouti B; Darbandi A
    J Appl Microbiol; 2021 Jun; 130(6):1823-1838. PubMed ID: 33098703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probiotics in the treatment of inflammatory bowel disease.
    Rioux KP; Fedorak RN
    J Clin Gastroenterol; 2006 Mar; 40(3):260-3. PubMed ID: 16633133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of dietary supplements in inflammatory bowel disease: a systematic review.
    Rossi RE; Whyand T; Murray CD; Hamilton MI; Conte D; Caplin ME
    Eur J Gastroenterol Hepatol; 2016 Dec; 28(12):1357-1364. PubMed ID: 27769076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antioxidant Supplements and Gastrointestinal Diseases: A Critical Appraisal.
    Khan I; Samson SE; Grover AK
    Med Princ Pract; 2017; 26(3):201-217. PubMed ID: 28278495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botanical Drugs as an Emerging Strategy in Inflammatory Bowel Disease: A Review.
    Algieri F; Rodriguez-Nogales A; Rodriguez-Cabezas ME; Risco S; Ocete MA; Galvez J
    Mediators Inflamm; 2015; 2015():179616. PubMed ID: 26576073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.
    Magro F; Portela F
    BioDrugs; 2010 Dec; 24 Suppl 1():3-14. PubMed ID: 21175228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale for probiotic and antibiotic treatment strategies in inflammatory bowel diseases.
    Schultz M; Schölmerich J; Rath HC
    Dig Dis; 2003; 21(2):105-28. PubMed ID: 14571109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probiotics and prebiotics in Crohn's disease therapies.
    Lichtenstein L; Avni-Biron I; Ben-Bassat O
    Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):81-8. PubMed ID: 27048899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic review: the efficacy of herbal therapy in inflammatory bowel disease.
    Ng SC; Lam YT; Tsoi KK; Chan FK; Sung JJ; Wu JC
    Aliment Pharmacol Ther; 2013 Oct; 38(8):854-63. PubMed ID: 23981095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders.
    Currò D; Ianiro G; Pecere S; Bibbò S; Cammarota G
    Br J Pharmacol; 2017 Jun; 174(11):1426-1449. PubMed ID: 27696378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventive health measures in inflammatory bowel disease.
    Abegunde AT; Muhammad BH; Ali T
    World J Gastroenterol; 2016 Sep; 22(34):7625-44. PubMed ID: 27678347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.